At the End of Every Pandemic: Beginning a Pandemic Playbook to Respond to the Next.

COVID-19 management pandemic planning playbook preparedness response system

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 17 12 2021
accepted: 31 03 2022
entrez: 16 5 2022
pubmed: 17 5 2022
medline: 20 5 2022
Statut: epublish

Résumé

The world was unprepared for COVID-19. Pandemics can unfold quickly; faster than governments can respond, unless they have maintained a realistic pandemic playbook. As the world ahead becomes ever-more complex, such playbook becomes ever-more necessary. This article not only describes the importance of a pandemic playbook but also a system to maintain it. A pandemic playbook both (1) specifies what is needed to respond to a pandemic and (2) provides a lens through which to identify measures that will keep people safe and society secure. The plays in the book are thought-though policies and strategies and corresponding implementation plans. The process of developing a playbook is as important as the product. Any playbook must be fit for purpose in the context of the times in which it is to be used. Above all, it must contain realistic policies and plans that can actually be implemented and can realize their intended effects. Achieving this goal requires (1) repeatedly exercising the playbook so that people know what to do when they need to do it and (2) evaluating results and updating the playbook to keep it relevant and current. Necessarily, to bring ideas alive, this article illustrates them with reference to COVID-19 and earlier pandemics, but it is not intended as a playbook for responding to the next pandemic; nor a postmortem on responses to COVID-19. Instead, it describes actions to take now to be ready when the next global pandemic strikes, so that policy decision-makers will not be lamenting "we should have done that."

Identifiants

pubmed: 35570978
doi: 10.3389/fpubh.2022.838561
pmc: PMC9093215
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

838561

Informations de copyright

Copyright © 2022 Goldschmidt.

Déclaration de conflit d'intérêts

The Author is the Founder/President of the World Development Group, Inc., a consultancy. In writing the article, the author was not influenced by any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Emerg Infect Dis. 1999 Mar-Apr;5(2):195-203
pubmed: 10221870
Nature. 2020 Aug;584(7819):26-29
pubmed: 32753759
J Med Syst. 2020 Nov 25;45(1):3
pubmed: 33237366
Epidemiology. 2013 Mar;24(2):179-83
pubmed: 23377087
Lancet Glob Health. 2021 May;9(5):e711-e720
pubmed: 33865476
N Engl J Med. 2021 Apr 1;384(13):1181-1184
pubmed: 33793147
PLoS One. 2020 Nov 5;15(11):e0241826
pubmed: 33152034
Lancet. 2021 Jul 10;398(10295):101-103
pubmed: 33991477
Front Public Health. 2020 Jul 14;8:356
pubmed: 32760690
J Cardiovasc Med (Hagerstown). 2020 Oct;21(10):838-839
pubmed: 32740445
Bull World Health Organ. 2012 Nov 1;90(11):800-1
pubmed: 23226890
Emerg Infect Dis. 2013;19(9):1478-83
pubmed: 23968598
Am J Trop Med Hyg. 2020 Oct;103(4):1621-1629
pubmed: 32783794
JAMA. 2020 Oct 20;324(15):1495-1496
pubmed: 33044484

Auteurs

Peter G Goldschmidt (PG)

World Development Group, Inc, Bethesda, MD, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH